Tonya Winders, MBA, CEO and president of the Allergy & Asthma Network, highlights what she is looking forward to at the European Respiratory Society (ERS) International Congress 2021.
Tonya Winders, MBA, CEO and president of the Allergy & Asthma Network, highlights what she is looking forward to at the European Respiratory Society (ERS) International Congress 2021.
Transcript:
What is your session on asthma guidelines going to entail?
So, I'm excited to attend the European Respiratory Society meeting and to participate in this particular session, which highlights the health care system failures for patients that are living with chronic respiratory disease. So, I'll be bringing forth the patient perspective on how current national policies are lacking for so many patients across the world to ensure that they're getting adequate diagnosis, treatment, and management of their chronic respiratory disease.
What other sessions are you looking forward to hearing about?
Well, it's always exciting to be with the world's leaders at the ERS meetings and to hear the latest science when it comes to chronic respiratory disease. So, I'm certainly looking forward to the sessions on asthma and COPD [chronic obstructive pulmonary disease]. I'm very interested in the COVID-19 long haul and how it may be impacting this community specifically. Again, we were seeing that and hearing that directly from the patient community on a daily basis. So, learning what the latest science and thoughts are on COVID-19 long haul and its relationship to asthma and COPD, specifically, is what I'm looking forward to.
The Pivotal Role of Payers in Improving Health Equity, Maternal Health Care in the US
March 26th 2024A presentation at the Greater Philadelphia Business Coalition on Health's 2024 Women’s Health Summit discussed how payers, including employers and public entities, can strategically influence health care purchasing to prioritize maternal health and equity.
Read More
Exploring Medicare Advantage Prior Authorization Variations
March 26th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the March 2024 issue of The American Journal of Managed Care® about their findings on variations in prior authorization use across Medicare Advantage plans.
Listen
Dr Al Benson on Reimbursement for Supportive Care When Treating Patients With Cancer
March 22nd 2024Al Benson, MD, FACP, FACCC, FASCO, medical oncologist at Northwestern University Feinberg School of Medicine and associate director of the Robert E. Tillery Comprehensive Cancer Center, discussed findings from a national survey assessing barriers to comprehensive cancer care delivery.
Read More
Dupilumab Considered Safe, Effective Treatment for Adolescent, Adult Patients With AD
March 20th 2024These posters both used the GLOBOSTAD study, which demonstrated through patient and physician assessments that dupilumab is a safe and effective treatment for adolescent and adult patients with atopic dermatitis (AD).
Read More